• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Conjunctival Neoplasms

Conjunctival Neoplasms - 4 Studies Found

Completed : Effect of Ranibizumab on Malignant Conjunctival Neoplasia
: Conjunctival Neoplasms
: 2007-04-03
: Drug: ranibizumab Subconjunctival injection of drug every 2 to 4 weeks
Terminated : Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
:
  • Intraocular Melanoma
  • Malignant Conjunctival Neoplasm

: 2007-06-04
:
  • Drug: cyclophosphamide 25-50 m

Completed : Vaccine Therapy in Treating Patients With Advanced Melanoma
:
  • Intraocular Melanoma
  • Malignant Conjunctival Neoplasm
  • : 2008-06-25
    :
    • Biological: incomplete Freund's adjuvant

Completed : Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
:
  • Intraocular Melanoma
  • Malignant Conjunctival Neoplasm
  • : 2007-05-08
    :
    • Biological: Peptide vaccine Mu

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.